Combination Treatment of SGLT2 Inhibitors and GLP-1 Receptor Agonists: Symbiotic Effects on Metabolism and Cardiorenal Risk
Crossref DOI link: https://doi.org/10.1007/s13300-018-0420-6
Published Online: 2018-04-05
Published Print: 2018-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goncalves, Edison http://orcid.org/0000-0002-7887-1231
Bell, David S. H.
Article History
Received: 21 January 2018
First Online: 5 April 2018